BioCentury
ARTICLE | Company News

atugen, Serono in validation deal

June 28, 2001 7:00 AM UTC

atugen (Berlin, Germany) will use its gene target validation services on certain cell lines supplied by the Serono Pharmaceutical Research Institute, a division of Serono (SWX:SEO; SRA) with the aim o...